Use of anti-IL 17A for psoriasis is not necessarily contraindicated in organ transplantation patients

Eur J Dermatol. 2020 Jun 1;30(3):311-313. doi: 10.1684/ejd.2020.3776.

Authors

Ambra Di Altobrando¹, Rossella Lacava¹, Annalisa Patrizi¹, Lidia Sacchelli¹, Gaetano La Manna², Giorgia Comai², Federico Bardazzi¹

Affiliations

¹ Department of Experimental, Diagnostic and Specialty Medicine- Division of Dermatology, University of Bologna, Bologna, Italy.
² Department of Transplant and Organ Failure, University of Bologna, Bologna, Italy.

PMID: 32540794
DOI: 10.1684/ejd.2020.3776

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Contraindications, Drug
Dermatologic Agents / therapeutic use*
Humans
Interleukin-17 / antagonists & inhibitors
Kidney Transplantation
Male
Psoriasis / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
IL17A protein, human
Interleukin-17
ixekizumab